These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6981168)

  • 1. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.
    Hammerschlag MR
    Rev Infect Dis; 1982; 4(2):500-5. PubMed ID: 6981168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
    Wallace RJ; Wiss K; Bushby MB; Hollowell DC
    Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of concomitant Neisseria gonorrhoeae and Chlamydia trachomatis infections in women: comparison of trimethoprim-sulfamethoxazole with ampicillin-probenecid.
    Brunham RC; Kuo C; Stevens CE; Holmes KK
    Rev Infect Dis; 1982; 4(2):491-9. PubMed ID: 6981167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of sulphamethoxazole/trimethoprim and sulfadoxine/pyrimethamine against Chlamydia trachomatis SA2f in McCoy cell culture.
    Mumtaz G; Ridgway GL; Felmingham D
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):415-7. PubMed ID: 3137048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
    Bismuth R; Jarlier V; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of gonorrhea with trimethoprim-sulfamethoxazole.
    Elliott WC; Reynolds G; Thornsberry C; Kellogg DS; Jaffe HW; Brown ST; Armstrong J; Rein MF
    J Infect Dis; 1977 Jun; 135(6):939-43. PubMed ID: 405433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination.
    Marks MI; Kazemi M; MacKay E
    Antimicrob Agents Chemother; 1973 Nov; 4(5):555-9. PubMed ID: 4791490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia.
    Wallace RJ; Septimus EJ; Williams TW; Conklin RH; Satterwhite TK; Bushby MB; Hollowell DC
    Rev Infect Dis; 1982; 4(2):315-25. PubMed ID: 6981158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sulfamethoxazole-trimethoprim synergistic action against members of the family Enterobacteriaceae with a two-plate agar dilution breakpoint MIC system.
    Ward PB; Carson M; Dodd JS; Pavillard ER
    J Clin Microbiol; 1984 Jun; 19(6):899-901. PubMed ID: 6381529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
    Pelton SI; Shurin PA; Klein JO; Finland M
    Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci.
    Najjar A; Murray BE
    Antimicrob Agents Chemother; 1987 May; 31(5):808-10. PubMed ID: 3111362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.
    Kirven LA; Thornsberry C
    Antimicrob Agents Chemother; 1974 Dec; 6(6):869-70. PubMed ID: 4548834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
    Segreti J; Kessler HA; Kapell KS; Trenholme GM
    Antimicrob Agents Chemother; 1987 Jan; 31(1):100-1. PubMed ID: 2952061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
    Yogev R; Moxon ER
    J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.